Latest Breaking News On - Byrd alzheimer center - Page 1 : comparemela.com

Psilera Bioscience Obtains DEA Approval to Conduct Cutting Edge Psychedelics Research Share Article The Drug Enforcement Administration green lights Psilera’s mission to study new DMT and psilocybin treatments for central nervous system disorders We are focused on novel delivery mechanisms to harness neurological benefits while making these treatments more accessible to patients in need. TAMPA, Fla. (PRWEB) February 25, 2021 Psilera Bioscience (“Psilera”) in collaboration with the University of South Florida (“USF”) and its Chemical Purification and Screening facility has received DEA approval to research DMT, psilocybin, and psilocin (the active ingredients naturally found in ayahuasca tea and magic mushrooms). Psilera and USF join only a handful of prestigious U.S. universities to undertake psychedelics research. Psilera will initiate research programs in its quest to become the first psychedelics co

Florida
United-states
University-of-south-florida
Tampa
Psilera-bioscience
Chris-witowski
Byrd-alzheimer-center
Health-neuroscience-institute
Research-park
South-florida
Chemical-purification
Neuroscience-institute